This raised questions about whether GLP-1RAs could cause pancreatic effects beyond pancreatitis, including the development of PDAC
10 Proof-of-concept treatments were validated in Pfa1 cells, which were knocked out of endogenous GPX4 and transfected to overexpress murine mScarlet-tagged GPX4 WT (red) or GPX4 R152H (blue)
This helps eliminate the possibility of conditions like infection, anemia, and others
Biochemistry 42 , 1471114719 (2003)
Based on publicly available information, those states are: Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, and Wisconsin
Yes, baseline and periodic eye examinations are recommended even when using GLP-1 medications primarily for weight management rather than diabetes